The company also delayed its break-even timeline from 2026 to 2028. View of Moderna company office entrance exterior with logo sign in Cambridge, Massachusetts, June 14, 2024. Shares fell 19 ...

Pfizer in a statement said Do No Harm's claims were without merit and that it was "proud of its commitment to diversity, equity, and inclusion." Virginia-based Do No Harm, which is a non-profit ...

(Reuters) -A U.S. appeals court on Friday revived a lawsuit by a conservative group opposed to diversity initiatives in medicine that challenged a Pfizer fellowship program designed to boost the ...

Jan 10 (Reuters) - Pfizer's (PFE.N), opens new tab experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of certain complications ...

A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year. Demand for the drugmaker’s Paxlovid treatment spurred by the latest ...

to investigate the nationwide push by the Biden administration for the use of two Covid vaccines made by Pfizer and Moderna, which both use mRNA technology. The grand jury completed its work in ...

That’s how much Penn will receive after settling a lawsuit with the German drug manufacturer BioNTech, which, with Pfizer, made their blockbuster ... Weissman won a Nobel Prize — to BioNTech and ...

the Pfizer vaccine is the only one available to people below the age of 18, so adolescents don’t need to worry about the potential for mixing and matching their boosters at the moment. Moderna ...

What about an mRNA vaccine for H5N1? There isn't one yet, but several companies—including Moderna, Pfizer and GlaxoSmithKline (in collaboration with CureVac)—are working on such a shot.

Less than a year after China identified the virus, health authorities in the U.S. and Britain cleared vaccines made by Pfizer and Moderna. Years of earlier research — including Nobel-winning ...